The excretion of catecholamines and the changes in plasma concentration of free fatty acids during aminophylline administration were explored. The relationships be tween cardiac arrhythmia, cardiac rate, and change in blood pressure under the conditions of these experiments were defined. Eighteen experiments were performed on eight volunteers. Blood pressures and heart rates before and during aminophylline infusion were recorded at frequent intervals, and urine and blood were collected during the control and infusion periods and in some subjects after the infusion. Loading with ethanol, glucose, or placebo before administration of aminophvlline was used.
SUMMARY
The excretion of catecholamines and the changes in plasma concentration of free fatty acids during aminophylline administration were explored. The relationships be tween cardiac arrhythmia, cardiac rate, and change in blood pressure under the conditions of these experiments were defined. Eighteen experiments were performed on eight volunteers. Blood pressures and heart rates before and during aminophylline infusion were recorded at frequent intervals, and urine and blood were collected during the control and infusion periods and in some subjects after the infusion. Loading with ethanol, glucose, or placebo before administration of aminophvlline was used.
These studies demonstrated that intravenous infusion of aminophylline increases the urinary excretion of epinephrine and norepinephrine in man, the rate of excretion of epinephrine being greater than that of norepinephrine. This increase was accompanied by an increase in the concentration of free fatty acids in the plasma. ADDTTIONAL 
Methods
Eighteen experiments were performed on eight male volunteers ranging in age from 23 to 42 years. On the morning of the experiment, the subjects ate a light breakfast consisting of cereal and milk. Neither coffee nor cigarettes were allowed prior to or during the experiment. An indwelling forearm intravenous needle was kept patent by a slow (0.75 ml/min) infusion of 5% glucose in water throughout the experiment. After the initial urine was discarded, the subjects assumed a supine position and were given 500 to 1,000 ml of water orally, maintaining a positive water balance for the duration of the experiment. The blood pressures and heart rates before and during aminophylline infusion were recorded for 10 of the 12 studies at frequent intervals (2 to 5 min). The subjects voided at 15 to 30 minute intervals during the control (-60 to 0 min) and infusion (0 to 75 min) periods. In several subjects postinfusion (75 to 135 min) ATUK ET AL. urines were collected in the same manner. When oral theophylline was employed, it was given at the onset of the infusion period, and the urine collections were made similarly. Anxiety and discomfort were minimized as much as possible.
In six experiments, the subjects were primed with ethanol (45 ml in the form of 3 ounces of 100 proof whiskey) at -60 min. Aminophylline, 500 mg/ 100 ml of 5% dextrose in water, was then administered at a constant rate during the infusion period. In six additional studies the subjects received 50 g of glucose orally at -60 min instead of ethanol, followed by aminophylline in the usual fashion. Placebo studies were carried out in six subjects who received, without their knowledge, isotonic saline rather than aminophylline during the infusion period.
Urine was analyzed for epinephrine (E) and norepinephrine (NE) by the von Euler method. 6 In all instances, 50-ml aliquots of urine were used. After the urine was boiled and filtered, the disodium salt of ethylene diamine tetra-acetic acid (EDTA) was added, pH was adjusted to 8.5 with 0.5 N NaOH, before it was passed through an aluminum oxide column. E The systolic and diastolic blood pressures and heart rates before and during aminophylline infusion were recorded for 10 of the 12 studies at frequent intervals. The mean systolic blood pressure increase in four subjects was 11 mm Hg (range + 3 to + 16); in six subjects it remained unchanged. The mean increase in diastolic pressure in eight subjects, was 7 mm Hg (range + 3 to + 14); in one it fell by 4 mm Hg and in another remained unchanged.
The heart rate in one subject increased (+ 5 beats/min), in another decreased (-10 beats/ min), and in the remaining showed no significant change. In two subjects, premature ventricular contractions occurred during aminophylline infusion and disappeared after the termination of the infusion. Two subjects developed tachycardia (120 and 130 beats/min) on standing up after the termination of the experiment. The Valsalva maneuver in one of these subjects (N.A.) slowed the heart rate to the normal range abruptly, with a brief period of nodal rhythm.
Urinary Cathecholamine Response
In the six ethanol-primed subjects, E excretion was increased during aminophylline infusion; the mean control excretion rate was 1.41 + 0.67 kg/hr, and that during aminophylline infusion was 4.14 ± 1.65 .tg/hr. The mean difference was not statistically significant. The excretion of NE was also increased in these subjects, the mean control excretion rate being 1.44 ± 0.49 ,ug/hr and during the infusion period being 3.13 + 0.70 1ug/hr (P < 0.01).
In the glucose-primed subjects, the urinary excretion of E was increased in all instances, and that of NE, in all but one, during the aminophylline infusion. The mean control value for E was 1.58 ± 0.44 j1g/hr and for NE was 1.44 ± 0.38 ,ug/hr. During the infusion the mean value for E was increased to 4.82 ± 0.50 pug/hr (P<0.01) and for NE to 3.13±0.69 ug/hr (P<0.05).
Placebo saline infusion did not alter E and NE excretion rate in six subjects.
The magnitude of the urinary catecholamine response varied considerably from individual to individual. However, a significant increase in the urinary excretion of E and NE correlated well with a significant rise in the diastolic blood pressure in eight of the 10 subjects. In one subject, the increased excretion of both catecholamines was not accompanied by any change in blood pressure. In another AMINOPHYLLINE ON URINARY CATECHOLAMINES Figure 1 The urinary catecholamine and plasma FFA response to aminophylline given intravenously to an ethanol-primed subject (J.L.) and to a glucose-primed subject (C.A.), with placebo experiments as indicated.
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this rate was highest in the first collection period (15 to 30 min) (see subject C.A., fig. 3 reported to be abolished in reserpine fed hens13 and with restoration of the diuretic effect later by administering the free catecholamine precursor, dopamine.14 This evidence supports our view that catecholamines play an intermediary role in this diuretic effect. The possibility that this increased catecholamine excretion could be due to the increased glomerular filtration rate is not supported by our data.
The role of the system which actively transports E from blood to urine across the tubule cell is also to be considered. It is known that E is transported by the organic acid pathway.15 It has been reported also that not more than 10% of the aminophylline is excreted intact; the remainder is broken down and excreted as methylxanthines or as methyluric acid.3 Such substances would not reasonably be expected to augment E excretion simply by interfering with the active transport sys- tem. This circumstance is also true in part for the NE transport system.16 Ethanol has been shown to cause an increase in urinary excretion of E and NE in man"1 17 and in the cat.18 Acute sublethal alcohol intoxication of intact unanesthetized dogs is accompanied by a marked increase in urinary excretion of E and NE.'9 Since this effect was present to some extent in the ethanol-primed subjects, catecholamine excretion was compared in ethanol-primed subjects with that of subjects who were given aminophylline alone. The comparison of the excretion rates between the two groups showed no significant difference. E and NE have been found to promote fat mobilization, as demonstrated by experiments both in vitro20' 21 In the light of these observations, our demonstrated increases in the plasma FFA levels and the peak responses suggest the release of large quantities of catecholamines following aminophylline infusion.
The question arises whether the FFA increase is directly related to the increased release of E and NE as produced by the ethanol or indirectly related to aminophylline. In the rat, the observations of Brodie and Maickel24 and Mallov25 indicated that the increase in plasma FFA occurred when intoxicating doses of alcohol were given. In these experiments blood levels of alcohol increased above 200 mg/100 ml. However, Freinkel and associates26 have found that ethanol infusion induces an early decline in FFA levels, dissociated from any effect on blood glucose and that this decline persists for as long as 2 hours despite plasma ethanol levels as high as 100 mg/ 100 ml. In the present study plasma FFA levels were followed in two subjects following ethanol ingestion alone. A typical FFA curve is depicted in figure 4 . In this subject as in the other one plasma FFA levels decreased after ethanol alone.
The modified FFA response to aminophylline in our glucose-primed subjects does not vitiate the possibility of increased catecholamine elaboration, for it has been recently shown27 that prior or concomitant administration of glucose modified the rise of FFA levels after administration of epinephrine.
The possible role of emotional stress in the release of catecholamines and promotion of fat mobilization has been considered. Anxiety and tension may be accompanied by an increase in the excretion of catecholamines28-30 as shown in experiments conducted in man31 33 and in animals.22 Stimulation of the autonomic nervous system has been found to influence the plasma FFA level also. Although it is not possible to separate entirely psychophysiological and pharmacological responses, extreme care was taken to reduce anxiety and discomfort in our subjects during these experiments. Placebo infusion was not associated with a significant increase in urinary excretion of catecholamines or with a rise in FFA levels. It was hoped that anxiety and stress would be further minimized by administration of theophylline by mouth. The results, shown in figure 5 , indicate that the drug has the same effect on urinary catecholamines and plasma FFA levels. This approach has the additional advantage of using xanthine without ethylene diamine.
At present, the rise of urinary excretion rates of NE and E is considered to be a good measure of sympathetic and adrenomedullary activity. 29 Admittedly, rebinding of free NE and its rapid transformation into its metabolites after its release may influence its appearance in the urine. But increased secretion from the adrenal medulla is the most likely explanation for the increased urinary excretion of E.
In view of the observations, our demonstrated increase in urinary excretion of both The urinary catecholamine and plasma FFA response to oral administration of theophylline.
E and NE, with relatively high values for the former, suggests that aminophylline stimulates the adrenal gland to release these catecholamines. Whether or not aminophylline similarly causes release of catecholamines from the sympathetic system cannot be determined by this study. Conclusions 1. Urinary epinephrine and norepinephrine excretions are found to be significantly increased following intravenous infusion of aminophylline in therapeutic doses.
2. The increase in catecholamine excretion is accompanied by an increase in plasma FFA concentration, suggesting an increased rate of release of catecholamines.
3. It is suggested that aminophylline stimulates the adrenal medulla and possibly chromaffin tissue situated outside the adrenal gland to release catecholamines.
